Submission for OMB Review; Comment Request, 12596-12597 [2012-4973]
Download as PDF
12596
Federal Register / Vol. 77, No. 41 / Thursday, March 1, 2012 / Notices
deemed appropriate) discussing the
health effects of these ingredients.
HHS has delegated responsibility for
implementing the required information
collection to CDC’s Office on Smoking
and Health. Respondents are not
required to submit specific forms;
however, they are required to meet
reporting guidelines and to submit the
ingredient report by chemical name and
Chemical Abstract Service (CAS)
Registration Number, consistent with
accepted reporting practices for other
companies that are required to report
ingredients added to other consumer
products. Typically, respondents submit
respondent’s letterhead, by CD, threeinch floppy disk, or thumb drive.
Electronic mail submissions are not
accepted. Upon receipt and verification
of the annual nicotine and ingredient
report, OSH issues a Certificate of
Compliance to the respondent.
There are no changes to information
collection procedures or the estimated
burden per response. There is an
increase in total estimated burden due
to an increase in the estimated number
of respondents, from 11 to 13. There are
no costs to respondents other than their
time.
a summary report to CDC with the
ingredient information for multiple
products, or a statement that there are
no changes to their previously
submitted ingredient report.
Respondents may submit the required
information to CDC through a
designated representative. The
information collection is subject to strict
confidentiality provisions.
Ingredient reports for new SLT
products are due at the time of first
importation. Thereafter, ingredient
reports are due annually on March 31.
Information is submitted to OSH by
mailing a written report on the
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondents
Form name
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Total burden
(in hours)
Smokeless Tobacco Manufacturers,
Packagers, and Importers.
SLT Nicotine and Ingredient and
Report.
13
1
1,713
22,269
Kimberly S. Lane,
Reports Clearance Officer, Centers for Disease
Control and Prevention.
[FR Doc. 2012–4950 Filed 2–29–12; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Submission for OMB Review;
Comment Request
mstockstill on DSK4VPTVN1PROD with NOTICES
Title: Objective Work Plan (OWP),
Objective Progress Report (OPR) and
Project Abstract.
OMB No.: 0980–0204.
Description: Content changes are
being proposed for the OPR and OWP
ONLY. The information in the OPR is
collected on a quarterly basis to monitor
the performance of grantees and better
gauge grantee progress. The
standardized format allows ANA to
report results across all its program
areas and flag grantees that may need
additional training and/or technical
assistance to successfully implement
their projects. The following are
proposed changes within specific
sections of the OPR form:
Objective Work Plan Update Section:
ANA has added fields for 1st through
4th Quarter (Q1,Q2,Q3,Q4) to report the
results for activities within each Project
Objective. The grantee may continue to
add to this form each quarter (rather
than to a new form), reflecting
cumulative results throughout the
project period instead of a single
quarter.
Financial Section: ANA has added 2
questions to: (1) Provide details on any
income generated as a result of ANA
project activities; (2) Provide details on
any changes made to the budget during
the reporting period.
Native American Youth and Elder
Opportunities Section: ANA has added
a question to: (1) Request details on any
intergenerational activities between
grandparents and their grandchildren.
Finally, ANA has added a new section
(last section) to the form titled:
PROJECT SUSTAINABILITY, to: (1)
Request details on the grantee’s
intention to continue the project
benefits and/or services after ANA’s
funding period for the project has
ended.
End of Changes to the OPR
The OWP: The information collected
through the OWP is needed to properly
administer and monitor the
Administration for Native Americans
(ANA) programs. The OWP assists
applicants in describing their projects’
objectives and activities, and also assists
independent panel reviewers, ANA staff
and the ANA Commissioner during
review and funding decision process.
Changes Specific Sections of the OWP
Problem Statement: ANA added a
field for applicants to include the
problem statement they identified in
their grant application.
Position Performing the Activity: On
the previous OWP, ANA requested
applicants to identify the position
responsible for each activity. ANA has
changed this title to ‘‘position
performing the activity’’ and applicants
are asked to identify the lead person in
one column and other support persons
in the second column.
End of Changes to the OWP
Project Abstract: The Project Abstract
form is no longer managed by ANA.
Respondents: Tribal Government,
Native Non-profit Organizations, Tribal
Colleges & Universities.
ANNUAL BURDEN ESTIMATES
Number of
respondents
Instrument
OWP ................................................................................................................
OPR .................................................................................................................
VerDate Mar<15>2010
17:25 Feb 29, 2012
Jkt 226001
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
500
275
E:\FR\FM\01MRN1.SGM
1
4
01MRN1
Average
burden hours
per response
3
1
Total burden
hours
1,500
1,100
Federal Register / Vol. 77, No. 41 / Thursday, March 1, 2012 / Notices
Estimated Total Annual Burden
Hours: 2,850.
Additional Information
Copies of the proposed collection may
be obtained by writing to the
Administration for Children and
Families, Office of Planning, Research
and Evaluation, 370 L’Enfant
Promenade SW., Washington, DC 20447,
Attn: ACF Reports Clearance Officer. All
requests should be identified by the title
of the information collection. Email
address: infocollection@acf.hhs.gov.
OMB Comment
OMB is required to make a decision
concerning the collection of information
between 30 and 60 days after
publication of this document in the
Federal Register. Therefore, a comment
is best assured of having its full effect
if OMB receives it within 30 days of
publication. Written comments and
recommendations for the proposed
information collection should be sent
directly to the following: Office of
Management and Budget, Paperwork
Reduction Project. Fax: 202–395–7285.
Email:
OIRA_SUBMISSION@OMB.EOP.GOV.
Attn: Desk Officer for the
Administration for Children and
Families.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 2012–4973 Filed 2–29–12; 8:45 am]
BILLING CODE 4184–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2011–N–0766]
Agency Information Collection
Activities; Submission for Office of
Management and Budget Review;
Comment Request; Survey of ‘‘Health
Care Providers’ Responses to Medical
Device Labeling’’
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing
that a proposed collection of
information has been submitted to the
Office of Management and Budget
(OMB) for review and clearance under
the Paperwork Reduction Act of 1995.
DATES: Fax written comments on the
collection of information by April 2,
2012.
mstockstill on DSK4VPTVN1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
17:25 Feb 29, 2012
Jkt 226001
To ensure that comments on
the information collection are received,
OMB recommends that written
comments be faxed to the Office of
Information and Regulatory Affairs,
OMB, Attn: FDA Desk Officer, FAX:
202–395–7285, or emailed to
oira_submission@omb.eop.gov. All
comments should be identified with the
OMB control number 0910–NEW and
title ‘‘Survey of ‘Health Care Providers’
Responses to Medical Device
Labeling’ ’’). Also include the FDA
docket number found in brackets in the
heading of this document.
FOR FURTHER INFORMATION CONTACT:
Daniel Gittleson, Office of Information
Management, Food and Drug
Administration, 1350 Piccard Dr., PI50–
400B, Rockville, MD 20850, 301–796–
5156, Daniel.Gittleson@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In
compliance with 44 U.S.C. 3507, FDA
has submitted the following proposed
collection of information to OMB for
review and clearance.
ADDRESSES:
Survey of ’’Health Care Providers’
Responses to Medical Device
Labeling’’—21 CFR Part 801 (OMB
Control Number 0910–NEW)
The purpose of this study is to
determine the most effective device
labeling format and inform an FDA’s
regulatory approach on standardized
device labeling. Building upon the
research methodology and success of
the approach FDA used to evaluate drug
labeling, we propose to ask health care
providers (HCPs) to evaluate the quality
of labeling (e.g. instructions for use,
directions) for a medical device and to
report the degree to which they could
follow those instructions, how useful
the information is, and how well
organized the information is. This work
will allow FDA to assess whether HCPs
find the format and content of device
labeling clear, understandable, useful,
and user-friendly. Findings will provide
evidence to inform FDA’s regulatory
approach to standardizing medical
device labeling across the United States.
In the Federal Register of November
1, 2011 (76 FR 67459), FDA published
a 60-day notice requesting public
comment on the proposed collection of
information.
Two comments were received,
however only one was related to the
Paperwork Reduction Act of 1995. In
response to the comments submitted by
Advamed, FDA responses are as
follows:
(Comment 1) Comment 1 questioned
whether the proposed collection of
information is necessary for the proper
performance of FDA’s functions,
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
12597
including whether the information will
have practical utility.
(Response) The survey is designed to
elicit responses on the formatting,
content, and design of the template and
not on the specific medical device
chosen. This is stated at the beginning
of the survey. FDA relies upon
knowledgeable researchers to develop
appropriate survey tools, and the
research methodology to test content,
format, and design of labeling is based
on their expertise. Drugs instructions
are written for all users, including
health care providers and patients. The
device labeling is written for all users,
including health care providers and
patients. We agree that industry could
provide recommended contents and
formats of labeling and encourage
industry to do so. This survey is
designed for the health care provider
and their feedback.
(Comment 2) Comment 2 questioned
the accuracy of FDA’s estimate of the
burden of the proposed collection of
information, including the validity of
the methodology and assumptions used.
(Response) The survey is designed to
elicit responses on the formatting,
content, and design of the template and
not on the specific medical device
chosen. The terms used in the templates
such as ‘‘warnings’’,
‘‘contraindications’’, and ‘‘brand name’’
are commonly used terms in labeling for
all devices. We are addressing what
should be in a shortened version of
labeling that will allow the user to
operate it safely. The survey was
designed by researchers with extensive
knowledge in the area of testing
labeling. It is anticipated that different
health care practitioners will provide
different answers based on their
experiences; this is why we chose to ask
various types of health care
practitioners. The objective of the
survey is to improve device labeling; it
would not be possible to do a survey
with a fictitious device that has no
intended use as per the suggestion. All
devices need to have intended use.
(Comment 3) Comment 3 questioned
ways to enhance the quality, utility, and
clarity of the information to be
collected.
(Response) We did not choose
biomedical engineers as part of this
survey because we wanted the people
who interact with the pump in the
presence of patients. The suggestion to
add a question about whether a health
care professional ever uses or reads
device labeling and how to improve
access to current device labeling was
done in a previous study with focus
groups. We developed the template
survey based on the responses we
E:\FR\FM\01MRN1.SGM
01MRN1
Agencies
[Federal Register Volume 77, Number 41 (Thursday, March 1, 2012)]
[Notices]
[Pages 12596-12597]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2012-4973]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
Submission for OMB Review; Comment Request
Title: Objective Work Plan (OWP), Objective Progress Report (OPR)
and Project Abstract.
OMB No.: 0980-0204.
Description: Content changes are being proposed for the OPR and OWP
ONLY. The information in the OPR is collected on a quarterly basis to
monitor the performance of grantees and better gauge grantee progress.
The standardized format allows ANA to report results across all its
program areas and flag grantees that may need additional training and/
or technical assistance to successfully implement their projects. The
following are proposed changes within specific sections of the OPR
form:
Objective Work Plan Update Section: ANA has added fields for 1st
through 4th Quarter (Q1,Q2,Q3,Q4) to report the results for activities
within each Project Objective. The grantee may continue to add to this
form each quarter (rather than to a new form), reflecting cumulative
results throughout the project period instead of a single quarter.
Financial Section: ANA has added 2 questions to: (1) Provide
details on any income generated as a result of ANA project activities;
(2) Provide details on any changes made to the budget during the
reporting period.
Native American Youth and Elder Opportunities Section: ANA has
added a question to: (1) Request details on any intergenerational
activities between grandparents and their grandchildren. Finally, ANA
has added a new section (last section) to the form titled: PROJECT
SUSTAINABILITY, to: (1) Request details on the grantee's intention to
continue the project benefits and/or services after ANA's funding
period for the project has ended.
End of Changes to the OPR
The OWP: The information collected through the OWP is needed to
properly administer and monitor the Administration for Native Americans
(ANA) programs. The OWP assists applicants in describing their
projects' objectives and activities, and also assists independent panel
reviewers, ANA staff and the ANA Commissioner during review and funding
decision process.
Changes Specific Sections of the OWP
Problem Statement: ANA added a field for applicants to include the
problem statement they identified in their grant application.
Position Performing the Activity: On the previous OWP, ANA
requested applicants to identify the position responsible for each
activity. ANA has changed this title to ``position performing the
activity'' and applicants are asked to identify the lead person in one
column and other support persons in the second column.
End of Changes to the OWP
Project Abstract: The Project Abstract form is no longer managed by
ANA.
Respondents: Tribal Government, Native Non-profit Organizations,
Tribal Colleges & Universities.
Annual Burden Estimates
----------------------------------------------------------------------------------------------------------------
Number of Average
Instrument Number of responses per burden hours Total burden
respondents respondent per response hours
----------------------------------------------------------------------------------------------------------------
OWP............................................. 500 1 3 1,500
OPR............................................. 275 4 1 1,100
----------------------------------------------------------------------------------------------------------------
[[Page 12597]]
Estimated Total Annual Burden Hours: 2,850.
Additional Information
Copies of the proposed collection may be obtained by writing to the
Administration for Children and Families, Office of Planning, Research
and Evaluation, 370 L'Enfant Promenade SW., Washington, DC 20447, Attn:
ACF Reports Clearance Officer. All requests should be identified by the
title of the information collection. Email address:
infocollection@acf.hhs.gov.
OMB Comment
OMB is required to make a decision concerning the collection of
information between 30 and 60 days after publication of this document
in the Federal Register. Therefore, a comment is best assured of having
its full effect if OMB receives it within 30 days of publication.
Written comments and recommendations for the proposed information
collection should be sent directly to the following: Office of
Management and Budget, Paperwork Reduction Project. Fax: 202-395-7285.
Email: OIRA_SUBMISSION@OMB.EOP.GOV. Attn: Desk Officer for the
Administration for Children and Families.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 2012-4973 Filed 2-29-12; 8:45 am]
BILLING CODE 4184-01-P